Aurobindo Pharma LtdNSE: AUROPHARMA

Press Release Apr 07 2026

Apr 7, 2026 at 6:18 PM EDT · Issued by Aurobindo Pharma Ltd

Filed with NSE · Apr 7, 2026 at 6:18 PM EDT · 3 pages · English

On 6ix: 6ix.com/news/press-release-apr-07-2026-20

Release

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated April 07, 2026, titled "Aurobindo Pharma receives USFDA approval for Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets".

Aurobindo Pharma Ltd on 6ix

Earlier from Aurobindo Pharma

Press Release Apr 06 2026Apr 6
Press Release Mar 04 2026Mar 4
Press Release Feb 26 2026Feb 26
Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040Feb 17
Press Release Feb 13 2026Feb 13

Later from Aurobindo Pharma

Press Release Apr 17 2026Apr 17
Press Release May 21 2026May 21
Press Release Jun 03 2026Jun 3
Press Release Jun 04 2026Jun 4
Aurobindo Pharma Ltd Press Release Jun 22 2026Jun 21

All Aurobindo Pharma news releases

Follow Aurobindo Pharma into a list and get an email when it puts out news.

Follow Aurobindo Pharma